lm6002 | Cer/Sph Mixture I
Ceramide/Sphingoid Internal Standard Mixture I
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Cer/Sph Mixture I
Ceramide/Sphingoid Internal Standard Mixture I
Sphingolipid Mix I contains 25 µM of 10 of these compounds in ethanol. Single use, 1 ml ampules are sufficient for at least 50 samples.
Catalog Number | Mixture Components | Target Concentration (µM) |
860640 | Sphingosine (C17 base) | 25 µM |
860654 | Sphinganine (C17 base) | 25 µM |
860641 | Sphingosine-1-P (C17 base) | 25 µM |
860655 | Sphinganine-1-P (C17 base) | 25 µM |
860545 | Lactosyl(ß) C12 Ceramide | 25 µM |
860583 | 12:0 Sphingomyelin | 25 µM |
860543 | Glucosyl(ß) C12 Ceramide | 25 µM |
860512 | 12:0 Ceramide | 25 µM |
860531 | 12:0 Ceramide-1-P | 25 µM |
860803 | 25:0 Ceramide | 25 µM |
Chiu S, Siri-Tarino P, Bergeron N, Suh JH, Krauss RM. A Randomized Study of the Effect of Replacing Sugar-Sweetened Soda by Reduced Fat Milk on Cardiometabolic Health in Male Adolescent Soda Drinkers. Nutrients. 2020 Feb 4;12(2):405. doi: 10.3390/nu12020405. PMID: 32033078; PMCID: PMC7071288.
PubMed ID: 32033078Azizkhanian I, Sheth SA, Iavarone AT, Lee S, Kakarla V, Hinman JD. Plasma Lipid Profiling Identifies Biomarkers of Cerebral Microvascular Disease. Front Neurol. 2019 Aug 29;10:950. doi: 10.3389/fneur.2019.00950. eCollection 2019.
PubMed ID: 31555203Jensen PN, Fretts AM, Yu C, Hoofnagle AN, Umans JG, Howard BV, Sitlani CM, Siscovick DS, King IB, Sotoodehnia N, McKnight B, Lemaitre RN. Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study. EBioMedicine. 2018 Dec 26. pii: S2352-3964(18)30623-6. doi: 10.1016/j.ebiom.2018.12.046. [Epub ahead of print]
PubMed ID: 30594552- Certificate of Analysis (Lot No. LM6002-LM17-056A and 6446EAA056)
- Certificate of Analysis (Lot No. LM6002-LM40-115A and 6446EAA115)